Literature DB >> 21185903

Antipsychotic dose and diminished neural modulation: a multi-site fMRI study.

C Abbott1, M Juárez, T White, R L Gollub, G D Pearlson, J Bustillo, J Lauriello, B Ho, H J Bockholt, V P Clark, V Magnotta, V D Calhoun.   

Abstract

BACKGROUND: The effect of antipsychotics on the blood oxygen level dependent signal in schizophrenia is poorly understood. The purpose of the present investigation is to examine the effect of antipsychotic medication on independent neural networks during a motor task in a large, multi-site functional magnetic resonance imaging investigation.
METHODS: Seventy-nine medicated patients with schizophrenia and 114 comparison subjects from the Mind Clinical Imaging Consortium database completed a paced, auditory motor task during functional magnetic resonance imaging (fMRI). Independent component analysis identified temporally cohesive but spatially distributed neural networks. The independent component analysis time course was regressed with a model time course of the experimental design. The resulting beta weights were evaluated for group comparisons and correlations with chlorpromazine equivalents.
RESULTS: Group differences between patients and comparison subjects were evident in the cortical and subcortical motor networks, default mode networks, and attentional networks. The chlorpromazine equivalents correlated with the unimotor/bitemporal (rho=-0.32, P=0.0039), motor/caudate (rho=-0.22, P=0.046), posterior default mode (rho=0.26, P=0.020), and anterior default mode networks (rho=0.24, P=0.03). Patients on typical antipsychotics also had less positive modulation of the motor/caudate network relative to patients on atypical antipsychotics (t(77)=2.01, P=0.048).
CONCLUSION: The results suggest that antipsychotic dose diminishes neural activation in motor (cortical and subcortical) and default mode networks in patients with schizophrenia. The higher potency, typical antipsychotics also diminish positive modulation in subcortical motor networks. Antipsychotics may be a potential confound limiting interpretation of fMRI studies on the disease process in medicated patients with schizophrenia.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21185903      PMCID: PMC3076294          DOI: 10.1016/j.pnpbp.2010.12.001

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  54 in total

1.  Functional effects of antipsychotic drugs: comparing clozapine with haloperidol.

Authors:  Adrienne C Lahti; Henry H Holcomb; Martin A Weiler; Deborah R Medoff; Carol A Tamminga
Journal:  Biol Psychiatry       Date:  2003-04-01       Impact factor: 13.382

2.  What is the best similarity measure for motion correction in fMRI time series?

Authors:  L Freire; A Roche; J F Mangin
Journal:  IEEE Trans Med Imaging       Date:  2002-05       Impact factor: 10.048

3.  The human brain is intrinsically organized into dynamic, anticorrelated functional networks.

Authors:  Michael D Fox; Abraham Z Snyder; Justin L Vincent; Maurizio Corbetta; David C Van Essen; Marcus E Raichle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-23       Impact factor: 11.205

4.  Estimating the number of independent components for functional magnetic resonance imaging data.

Authors:  Yi-Ou Li; Tülay Adali; Vince D Calhoun
Journal:  Hum Brain Mapp       Date:  2007-11       Impact factor: 5.038

5.  A rating scale for drug-induced akathisia.

Authors:  T R Barnes
Journal:  Br J Psychiatry       Date:  1989-05       Impact factor: 9.319

6.  A rating scale for extrapyramidal side effects.

Authors:  G M Simpson; J W Angus
Journal:  Acta Psychiatr Scand Suppl       Date:  1970

7.  Antipsychotic drug effects on motor activation measured by functional magnetic resonance imaging in schizophrenic patients.

Authors:  D F Braus; G Ende; W Weber-Fahr; A Sartorius; A Krier; P Hubrich-Ungureanu; M Ruf; S Stuck; F A Henn
Journal:  Schizophr Res       Date:  1999-08-23       Impact factor: 4.939

8.  An fMRI study of working memory in first-degree unaffected relatives of schizophrenia patients.

Authors:  Shashwath A Meda; Manish Bhattarai; Nicholas A Morris; Robert S Astur; Vince D Calhoun; Daniel H Mathalon; Kent A Kiehl; Godfrey D Pearlson
Journal:  Schizophr Res       Date:  2008-08-03       Impact factor: 4.939

9.  FDG-PET and MRI imaging of the effects of sertindole and haloperidol in the prefrontal lobe in schizophrenia.

Authors:  Monte S Buchsbaum; Mehmet Haznedar; Randall E Newmark; King-Wai Chu; Nicola Dusi; Jonathan J Entis; Kim E Goldstein; Chelain R Goodman; Adarsh Gupta; Erin Hazlett; James Iannuzzi; Yuliya Torosjan; Jane Zhang; Adam Wolkin
Journal:  Schizophr Res       Date:  2009-08-19       Impact factor: 4.939

10.  Schizophrenia and Parkinson's disease lead to equal motor-related changes in cortical and subcortical brain activation: an fMRI fingertapping study.

Authors:  Jürgen L Müller; Caroline Deuticke; Albert Putzhammer; Christian H Röder; Göran Hajak; Jürgen Winkler
Journal:  Psychiatry Clin Neurosci       Date:  2003-12       Impact factor: 5.188

View more
  25 in total

Review 1.  Function biomedical informatics research network recommendations for prospective multicenter functional MRI studies.

Authors:  Gary H Glover; Bryon A Mueller; Jessica A Turner; Theo G M van Erp; Thomas T Liu; Douglas N Greve; James T Voyvodic; Jerod Rasmussen; Gregory G Brown; David B Keator; Vince D Calhoun; Hyo Jong Lee; Judith M Ford; Daniel H Mathalon; Michele Diaz; Daniel S O'Leary; Syam Gadde; Adrian Preda; Kelvin O Lim; Cynthia G Wible; Hal S Stern; Aysenil Belger; Gregory McCarthy; Burak Ozyurt; Steven G Potkin
Journal:  J Magn Reson Imaging       Date:  2012-02-07       Impact factor: 4.813

Review 2.  Antipsychotic drug effects in schizophrenia: a review of longitudinal FMRI investigations and neural interpretations.

Authors:  C C Abbott; A Jaramillo; C E Wilcox; D A Hamilton
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

3.  Extracting intrinsic functional networks with feature-based group independent component analysis.

Authors:  Vince D Calhoun; Elena Allen
Journal:  Psychometrika       Date:  2012-10-02       Impact factor: 2.500

4.  Reducing Inter-Site Variability for Fluctuation Amplitude Metrics in Multisite Resting State BOLD-fMRI Data.

Authors:  Xinbo Wang; Qing Wang; Peiwen Zhang; Shufang Qian; Shiyu Liu; Dong-Qiang Liu
Journal:  Neuroinformatics       Date:  2021-01

Review 5.  Neuroimaging biomarkers for early drug development in schizophrenia.

Authors:  Jason R Tregellas
Journal:  Biol Psychiatry       Date:  2013-10-04       Impact factor: 13.382

6.  Dysmaturation of the default mode network in autism.

Authors:  Stuart D Washington; Evan M Gordon; Jasmit Brar; Samantha Warburton; Alice T Sawyer; Amanda Wolfe; Erin R Mease-Ference; Laura Girton; Ayichew Hailu; Juma Mbwana; William D Gaillard; M Layne Kalbfleisch; John W VanMeter
Journal:  Hum Brain Mapp       Date:  2013-01-18       Impact factor: 5.038

7.  Differential Patterns of Dysconnectivity in Mirror Neuron and Mentalizing Networks in Schizophrenia.

Authors:  Leonhard Schilbach; Birgit Derntl; Andre Aleman; Svenja Caspers; Mareike Clos; Kelly M J Diederen; Oliver Gruber; Lydia Kogler; Edith J Liemburg; Iris E Sommer; Veronika I Müller; Edna C Cieslik; Simon B Eickhoff
Journal:  Schizophr Bull       Date:  2016-03-02       Impact factor: 9.306

8.  Reliability of functional magnetic resonance imaging activation during working memory in a multi-site study: analysis from the North American Prodrome Longitudinal Study.

Authors:  Jennifer K Forsyth; Sarah C McEwen; Dylan G Gee; Carrie E Bearden; Jean Addington; Brad Goodyear; Kristin S Cadenhead; Heline Mirzakhanian; Barbara A Cornblatt; Doreen M Olvet; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Aysenil Belger; Larry J Seidman; Heidi W Thermenos; Ming T Tsuang; Theo G M van Erp; Elaine F Walker; Stephan Hamann; Scott W Woods; Maolin Qiu; Tyrone D Cannon
Journal:  Neuroimage       Date:  2014-04-13       Impact factor: 6.556

Review 9.  Targeting Functional Biomarkers in Schizophrenia with Neuroimaging.

Authors:  Korey P Wylie; Jason Smucny; Kristina T Legget; Jason R Tregellas
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

10.  Multifaceted genomic risk for brain function in schizophrenia.

Authors:  Jiayu Chen; Vince D Calhoun; Godfrey D Pearlson; Stefan Ehrlich; Jessica A Turner; Beng-Choon Ho; Thomas H Wassink; Andrew M Michael; Jingyu Liu
Journal:  Neuroimage       Date:  2012-03-13       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.